Tekla Capital Management LLC Intra Cellular Therapies, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 131,435 shares of ITCI stock, worth $9 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

131,435

Previous 172,371 23.75%

Holding current value

$9 Million

Previous $9.33 Million 10.83%

% of portfolio

0.33%

Previous 0.36%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$54.67 - $66.44 $2.24 Million - $2.72 Million	-40,936 Reduced 23.75%	131,435 $8.32 Million
Q3 2022 Nov 01, 2022	SELL	$42.7 - $59.99 $3.03 Million - $4.26 Million	-71,066 Reduced 29.19%	172,371 $8.02 Million
Q2 2022 Jul 29, 2022	SELL	$43.0 - $65.64 $2.04 Million - $3.12 Million	-47,499 Reduced 16.33%	243,437 $13.9 Million
Q1 2022 May 13, 2022	BUY	$38.74 - $62.09 $2.11 Million - $3.38 Million	54,489 Added 23.04%	290,936 $17.8 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $3.1 Million - $4.7 Million	-87,954 Reduced 27.11%	236,447 $12.4 Million

Q3 2021 Nov 12, 2021	BUY	$28.72 - $42.49 $3.49 Million - $5.17 Million	121,645 Added 60.0%	324,401 $12.1 Million
Q2 2021 Aug 13, 2021	SELL	$29.3 - $44.5 $870,796 - $1.32 Million	-29,720 Reduced 12.78%	202,756 $8.28 Million
Q1 2021 May 14, 2021	SELL	$30.8 - $39.51 $4.12 Million - $5.28 Million	-133,700 Reduced 36.51%	232,476 $7.89 Million
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $6.35 Million - $8.76 Million	271,938 Added 288.57%	366,176 $11.6 Million
Q4 2019 Feb 13, 2020	BUY	$7.26 - $38.49 $484,169 - $2.57 Million	66,690 Added 242.09%	94,238 $3.23 Million
Q3 2019 Nov 13, 2019	SELL	$7.47 - $14.03 $205,783 - $386,498	-27,548 Reduced 50.0%	27,548 $206,000
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $586,783 - $787,336	-55,097 Reduced 50.0%	55,096 $715,000
Q4 2018 Feb 13, 2019	BUY	$10.36 - $20.96 $780,553 - $1.58 Million	75,343 Added 216.19%	110,193 $1.26 Million
Q3 2018 Nov 13, 2018	BUY	$17.77 - $22.9 $619,284 - $798,065	34,850 New	34,850 $756,000

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

77.7M

Call Options Held

1.7M

Put Options Held

1.13M

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.47B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Intra Cellular Therapies, Inc. Transaction History